Mechanistic studies of AV370, a potent FGFR3 antagonistic antibody

被引：0

作者：

Bai, Ailin ^{[1
]}

Winston, William ^{[1
]}

Meetze, Kristan ^{[1
]}

Kollipara, Sriram ^{[1
]}

Woo, Jin-Kyeung ^{[1
]}

Nhi Vo ^{[1
]}

Kosmatka, Monica ^{[1
]}

Breault, Lyne ^{[1
]}

Weiler, Solly ^{[1
]}

Kabbarah, Omar ^{[1
]}

Boudrow, Andrea ^{[1
]}

Connolly, Kelly ^{[1
]}

DiPrima, Michael ^{[1
]}

Tissire, Hamid ^{[1
]}

Jiang, Jinwei ^{[1
]}

Gyuris, Jeno ^{[1
]}

Weng, Zhigang ^{[1
]}

机构：

[1] AVEO Pharmaceut Inc, Cambridge, MA USA

来源：

CANCER RESEARCH | 2009年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3775

引用

页数：2

共 38 条

[31] Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma
Kamath, Amrita V.
Lu, Dan
Gupta, Priyanka
Jin, Denise
Xin, Yan
Brady, Ann
Stephan, Jean-Philippe
Li, Hao
Tien, Janet
Qing, Jing
Damico-Beyer, Lisa A.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1071 - 1078
[32] A Phase I Dose-escalation Study of MFGR1877S, a Human Monoclonal Anti-fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients (pts) with Advanced Solid Tumors
ODonnell, P.
Goldman, J. W.
Gordon, M. S.
Shih, K.
Choi, Y. J.
Lu, D.
Kabbarah, O.
Ho, W.
Rooney, I.
Lam, E. T.
EUROPEAN JOURNAL OF CANCER, 2012, 48 : 191 - 192
[33] A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
Trudel, Suzanne
Bergsagel, P. Leif
Singhal, Seema
Niesvizky, Ruben
Comenzo, Raymond L.
Bensinger, William I.
Lebovic, Daniel
Choi, YounJeong
Lu, Dan
French, Dorothy
Penuel, Elicia
Ho, William
Stewart, Keith
BLOOD, 2012, 120 (21)
[34] 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: Synthesis, pharmacological evaluation and mechanistic studies
Di Pietro, Ornella
Viayna, Elisabet
Vicente-Garcia, Esther
Bartolini, Manuela
Ramon, Rosario
Juarez-Jimenez, Jordi
Victoria Clos, M.
Perez, Belen
Andrisano, Vincenza
Javier Luque, F.
Lavilla, Rodolfo
Munoz-Torrero, Diego
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 73 : 141 - 152
[35] MRG006A, a novel glypican-3-targeting antibody-drug conjugate, demonstrated potent anti-tumor activity and good safety profile in preclinical studies
Wang, Yanchun
Li, Hongfeng
Shen, Hao
Liu, Wenchao
Liu, Shoujia
Yin, Kequan
Xu, Haili
Cui, Xueyuan
Li, Wei
Liu, Wei
Wu, Xiangyu
Yang, Liu
Ma, Tian
Zhao, Zhongrun
Wang, Jun
Cui, Feifei
Fang, Lei
Qin, Minmin
Hu, Chaohong
CANCER RESEARCH, 2024, 84 (06)
[36] Ultrasound mediated efficient synthesis of new 4-oxoquinazolin-3(4H)-yl) furan-2-carboxamides as potent tyrosinase inhibitors: Mechanistic approach through chemoinformatics and molecular docking studies
Dige, Nilam C.
Mahajan, Prasad G.
Raza, Hussain
Hassan, Mubashir
Vanjare, Balasaheb D.
Hong, Hansol
Lee, Ki Hwan
Latip, Jalifah
Seo, Sung-Yum
BIOORGANIC CHEMISTRY, 2019, 92
[37] Synthetic studies on himbacine, a potent antagonist of the muscarinic M2 subtype receptor.: Part 2:: Synthesis and muscarinic M2 subtype antagonistic activity of the novel himbacine congeners modified at the C-3 position of lactone moiety
Takadoi, M
Yamaguchi, K
Terashima, S
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) : 1169 - 1186
[38] Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic
Huang, Huoming
Li, Xueping
Xie, Peng
Li, Xinwei
Xu, XueJun
Qian, Yuanyuan
Yuan, Congmin
Meng, Xiangguo
Chai, JingRui
Chen, Jing
Liu, Jing
Wang, Wenli
Li, Wei
Wang, YuJun
Fu, Wei
Liu, Jinggen
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 9458 - 9483

← 1 2 3 4 →